Media
We strive to provide correct, relevant, balanced and clear information to shareholders, capital market, media and society, to facilitate understanding of our research, development and business operations.
Press release - November 17, 2023
Article with exploratory alkylator-refractory subgroup analysis from Oncopeptides’ OCEAN study observing longer PFS and OS in melflufen vs. pomalidomide published in European Journal of Haematology
Read press releaseLatest press releases
Media contact
David Augustsson
Director of Corporate Affairs
Image bank
Welcome to our image bank. Download pictures of our Management team, our board of directors & our logotype.
Image bank
Follow us on LinkedIn
Oncopeptides via e-mail
Image bank test
Lorem ipsum contact